Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUSIC-HFrEF1: SRD-001 in HFrEF
NCT04703842Phase 2Recruiting
- Sponsor
- Sardocor
- Start
- Sep 2021
- Primary completion
- Dec 2025
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure with reduced ejection fraction (HFrEF) comparing SRD-001 with Placebo (2 arms). Primary endpoints: Change from baseline in symptomatic parameters at 12 months, Change from baseline in physical parameter at 12 months and 3 more. Started Sep 2021; status: recruiting.
02
Drugs
SRD-001
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT04703842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04703842.